---
title: "YTHI plans to launch a restricted stock incentive plan for 3.12 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243101052.md"
description: "According to the Zhitong Finance APP, YTHI disclosed the draft of the 2025 restricted stock incentive plan, proposing to grant 3.12 million restricted shares, accounting for 0.58% of the company's total equity at the time of the plan announcement. This plan is a one-time grant with no reserved rights, and the total number of incentive recipients is 16, with a grant price of 6.10 yuan per share"
datetime: "2025-06-04T11:56:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243101052.md)
  - [en](https://longbridge.com/en/news/243101052.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243101052.md)
---

# YTHI plans to launch a restricted stock incentive plan for 3.12 million shares

According to the Zhitong Finance APP, YTHI (600817.SH) disclosed the draft of the 2025 restricted stock incentive plan, proposing to grant 3.12 million restricted shares, accounting for 0.58% of the company's total share capital at the time of the plan announcement. This plan is a one-time grant with no reserved rights, and the total number of incentive recipients is 16, with a grant price of 6.10 yuan/share

### Related Stocks

- [600817.CN](https://longbridge.com/en/quote/600817.CN.md)

## Related News & Research

- [The robber baron Long Island Rail Road strike](https://longbridge.com/en/news/286901134.md)
- [What NPS' new asset allocation, withdrawal options mean for you](https://longbridge.com/en/news/286678038.md)
- [Coffee prices aren’t the only problem. How retirees can fight inflation.](https://longbridge.com/en/news/286675059.md)
- [Your 3-6 months of emergency savings won't cut -2-](https://longbridge.com/en/news/286650242.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)